How many studies have been conducted on Akkermansia%20muciniphila?

BiohacksAI has indexed 463 PubMed studies on Akkermansia%20muciniphila, including 31 randomized controlled trials (RCTs). 33% of studies involve human subjects.

What are the main research areas for Akkermansia%20muciniphila?

The primary research domains for Akkermansia%20muciniphila are 🦠 Gut & Microbiome, 🔥 Metabolic, 🔬 Oncology. This is based on analysis of 463 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Akkermansia%20muciniphila

A genus of gram-negative, anaerobic bacteria in the phylum VERRUCOMICROBIA and the family Akkermansiaceae. This genus includes the species Akkermansia muciniphila which is known for residing in the human intestinal tract and having effects on human metabolism.

463+ PubMed studies analyzed · 31 RCTs · Evidence Score: 49.2

Research Domains

Akkermansia%20muciniphila has been studied across 15 research domains including 🦠 Gut & Microbiome, 🔥 Metabolic, 🔬 Oncology, 🛡️ Immunity, 🔬 Inflammation. The primary research focus is 🦠 Gut & Microbiome with 67% of studies addressing this area.

Loading evidence profile...

This evidence profile for Akkermansia%20muciniphila is generated deterministically from 463 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.